You say......."With TBI it will be a tablet form"
Where can I find this information?
The PR only states that the trials were......... "delivered intravenously ateither a 100 nmol/kg or 300 nmol/kg dose".
- Forums
- ASX - By Stock
- AGN
- Ann: ARG-007 Reduces Effects of TBI in Preclinical Study
Ann: ARG-007 Reduces Effects of TBI in Preclinical Study, page-17
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
87.0¢ |
Change
0.025(2.96%) |
Mkt cap ! $110.6M |
Open | High | Low | Value | Volume |
86.3¢ | 88.0¢ | 86.3¢ | $72.83K | 83.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5324 | 85.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.5¢ | 16365 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5324 | 0.855 |
1 | 1155 | 0.850 |
2 | 29281 | 0.845 |
1 | 639 | 0.840 |
1 | 10000 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.865 | 16365 | 1 |
0.870 | 12745 | 2 |
0.880 | 18908 | 1 |
0.885 | 2185 | 2 |
0.890 | 20752 | 4 |
Last trade - 10.53am 16/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online